Live Breaking News & Updates on Lishui Central

Stay updated with breaking news from Lishui central. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

16个项目落户溧水,宁杭合作迈出新步伐-南京搜狐焦点

16个项目落户溧水,宁杭合作迈出新步伐-南京搜狐焦点
nj.focus.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nj.focus.cn Daily Mail and Mail on Sunday newspapers.

Yangtze River , China General , Phnom Penh , Metro Lishui , Technology Service , Lishui Ning Hangzhou , Nanjing Sohu Focus Ning Hangzhou , Ning Hangzhou , Nanjing Municipal City Hall , Lishui Central , Genesis New Nanjing South , Lishui Airport Metro , Nanjing Country Agriculture , Nanjing Hangzhou , Metropolitan Area , District Yuhang , Lishui Manufacturing , Nanjing Airport Economy , Lishui Area Ning Hangzhou , Lishui District , Yangtze River Region , யாங்க்ட்ஜே நதி , சீனா ஜநரல் , ஃப்நாம் பென் , தொழில்நுட்பம் சேவை , பெருநகர பரப்பளவு ,

OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting

Share this article
Share this article
SHANGHAI, June 6, 2021 /PRNewswire/ On June 4, 2021 (EST), OriginCell Therapeutics (Shanghai) Co., Ltd. ( OriginCell ), together with Lishui Central Hospital affiliated to Zhejiang University and Shanghai Changzheng Hospital, presented the updated data from the on-going trial of Ori-CAR-001, a GPC3 CAR-T cell therapy for the treatment of relapsed/refractory hepatocellular carcinoma (HCC), at the 2021 annual meeting of American Society of Clinical Oncology. Preliminary results from the study show promising safety and efficacy of Ori-CAR-001 in patients with GPC3-positive relapsed/refractory HCC.
(PRNewsfoto/Yuanqi Biological Technology (Shanghai) Co., Ltd.)
(PRNewsfoto/Yuanqi Biological Technology (Shanghai) Co., Ltd.) ....

United States , Comunidad Autonoma De Cataluna , Ji Jiansong , European Association For The Study Of Liver , Key Laboratory Of Imaging Diagnosis , American Society Of Clinical Oncology , National Key Rd Program , National Medical Products Administration , Invasive Intervention Research Of Zhejiang China , Cell Therapy , Solid Tumors , Clinic Liver Cancer , European Association , Good Safety Profile , Professor Ji Jiansong , Lishui Central , Key Laboratory , Imaging Diagnosis , Minimally Invasive Intervention Research , Zhejiang China , Origincell Therapeutics , Investigational New Drug , American Society , Clinical Oncology , Yuanqi Biological Technology Shanghai Co , ஒன்றுபட்டது மாநிலங்களில் ,